nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
|
Serazin, Nathan A. |
|
|
39 |
22 |
p. 3028-3036 |
artikel |
2 |
Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap
|
Saitoh, Akihiko |
|
|
39 |
22 |
p. 3018-3024 |
artikel |
3 |
Chlamydia trachomatis: Cell biology, immunology and vaccination
|
Murray, Sam M. |
|
|
39 |
22 |
p. 2965-2975 |
artikel |
4 |
Developing standard safety outcomes for COVID-19 vaccines
|
Buttery, Jim P. |
|
|
39 |
22 |
p. 3025-3027 |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
22 |
p. IFC |
artikel |
6 |
Effective interventions to increase routine childhood immunization coverage in low socioeconomic status communities in developed countries: A systematic review and critical appraisal of peer-reviewed literature
|
Machado, Amanda Alberga |
|
|
39 |
22 |
p. 2938-2964 |
artikel |
7 |
Effect of early measles vaccination on long-term protection: A systematic review
|
Xu, Janine |
|
|
39 |
22 |
p. 2929-2937 |
artikel |
8 |
Efficient immunogenic peptide antigen delivery to dendritic cells using an ESCRT-mediated extracellular vesicle formation method
|
Kimura, Sakika |
|
|
39 |
22 |
p. 2976-2982 |
artikel |
9 |
Invasive pneumococcal disease in Canada 2010–2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines
|
Dion, Stephane B. |
|
|
39 |
22 |
p. 3007-3017 |
artikel |
10 |
Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study
|
Bianchi, Francesco Paolo |
|
|
39 |
22 |
p. 2989-2994 |
artikel |
11 |
Meeting report: WHO consultation on malaria vaccine development, Geneva, 15–16 July 2019
|
Vekemans, Johan |
|
|
39 |
22 |
p. 2907-2916 |
artikel |
12 |
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
|
Vogel, Tiphanie P. |
|
|
39 |
22 |
p. 3037-3049 |
artikel |
13 |
Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis
|
Ardura-Garcia, Cristina |
|
|
39 |
22 |
p. 2917-2928 |
artikel |
14 |
Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia
|
Sam, I-Ching |
|
|
39 |
22 |
p. 2983-2988 |
artikel |
15 |
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
|
Volkmann, Ariane |
|
|
39 |
22 |
p. 3067-3080 |
artikel |
16 |
The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG)
|
Chen, Robert T. |
|
|
39 |
22 |
p. 3050-3052 |
artikel |
17 |
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Munoz, Flor M. |
|
|
39 |
22 |
p. 3053-3066 |
artikel |
18 |
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
|
Custers, Jerome |
|
|
39 |
22 |
p. 3081-3101 |
artikel |
19 |
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
|
Hogan, Alexandra B. |
|
|
39 |
22 |
p. 2995-3006 |
artikel |